Big Pharma has been playing a costly game, manipulating the patent system to keep drug prices sky-high—even on medications developed with taxpayer funding.
At Accountable.US, we’ve uncovered how drug manufacturers use tactics like pay-to-delay, evergreening, patent thickets, and product hopping to block generic competition and maintain their grip on the market. These strategies have allowed companies to rake in billions while Medicare and U.S. taxpayers foot the bill—leaving many patients, especially in lower-income and marginalized communities, struggling to afford the medications they need.
Explore our in-depth research, press releases, and latest news as we expose Big Pharma’s abuses and advocate for accountability in drug pricing. Learn how we’re fighting back against these unfair practices to ensure affordable access to life-saving medications for all Americans.
